Committee begins hearings on fentanyl-induced homicide bill; recesses to continue testimony

The House Judiciary subcommittee opened testimony on House Bill 3591, a measure addressing fentanyl-related deaths, heard testimony from law enforcement and family members of overdose victims, and recessed to continue the record and vote after the House adjourns.

Sheriff Tony Bridal described fentanyl's rapid, lethal effect and urged lawmakers to broaden the bill's scope beyond fentanyl to cover other potent synthetic compounds, noting local overdose statistics: "If it's restricted just to fentanyl ... some attorneys will look for loopholes ... we had in 23, a hundred and 18 overdoses, 98 were fentanyl, and 9 were Xylazine," he told the committee. Bridal and the Sheriff's Association support broader "drug-induced homicide" language to avoid prosecution gaps if forensic findings later identify a different synthetic compound.

Several family members gave emotional testimony. Melissa Anderko described the 2024 death of her 16-year-old son, saying a toxicology report showed "8 times the lethal amount of fentanyl in his system" and that she learned under existing law that the dealer who supplied pills to her son could only face distribution charges absent a statute creating a homicide offense for fentanyl-related deaths.

Chairman Jeff Johnson told witnesses the committee would "recede to the call of the chair" and reconvene immediately after session adjournment to hear additional testimony and then proceed to vote; the committee did not take a final vote on the bill during the initial hearing.

Committee members expressed interest in hearing more testimony and indicated they will continue the record promptly so that impacted families, law enforcement and other stakeholders can provide additional evidence before any committee vote.